CRI-ENCI Ninth International Cancer Immunotherapy Conference

"Translating Science into Survival"

September 10-12, 2025 in Utrecht, The Netherlands

CICON25 will take place at the Jaarbeurs Beatrix Theater, just steps from the Utrecht train station.

Presented by the Cancer Research Institute (CRI) and the European Network for Cancer Immunotherapy (ENCI), the joint program committee has designed comprehensive sessions that will cover exciting new developments in the field of cancer immunology.

Please visit the conference website www.cancerimmunotherapyconference.org for more information.

Confirmed speakers:

Valsamo Anagnostou, Johns Hopkins Medicine, USA
Michal Bassani-Sternberg, Ludwig Institute for Cancer Research, Switzerland
Cedrik Britten, Immatics Biotechnologies, Germany
Sjoerd van der Burg, Leiden University Medical Center, The Netherlands
Tina Cascone, MD Anderson Cancer Center, USA
Myriam Chalabi, Netherlands Cancer Institute, The Netherlands
Karin de Visser, Netherlands Cancer Institute, The Netherlands
Dmitry Gabrilovich, AstraZeneca, USA
William L. Hwang, Harvard Medical School, USA
Arthur Krieg, University of Massachusetts RNA Therapeutics Institute/Zola Therapeutics, USA
Ignacio Melero, University of Navarra, Spain
Laurie Menger, Institut Gustave Roussy, France
Rienk Offringa, German Cancer Research Center (DKFZ), Germany
Juan Osorio, Rockefeller University, USA
Yardena Samuels, Weizmann Institute of Science, Israel
Catherine Sautès-Fridman, Cordeliers Research Centre, France
Ton Schumacher, Netherlands Cancer Institute, The Netherlands
Denis Wirtz, Johns Hopkins University, USA
Catherine Wu, Harvard University, USA